Patient Guide: A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in Children and Adolescents Who Have Received a Hematopoietic Stem Cell Transplant (HSCT) or a Solid Organ Transplant (SOT)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 47 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05319353
Status: 🟢 Enrolling Now
Condition: Cytomegalovirus Infections
Phase: PHASE3

Where You Can Participate

This study is available at 47 locations across the country.

Top locations include:
  • • Omaha, Nebraska
  • • Cincinnati, Ohio
  • • Fort Worth, Texas
  • • And 44 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in Children and Adolescents Who Have Received a Hematopoietic Stem Cell Transplant (HSCT) or a Solid Organ Transplant (SOT) - Join Clinical Trial NCTNCT05319353

How to Join This Clinical Trial - NCTNCT05319353

Learn how to participate in this PHASE3 trial studying an investigational therapy for Cytomegalovirus Infections. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Cytomegalovirus Infections. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Cytomegalovirus Infections
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05319353 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 47 locations. Find a study site near you:

Clinical Research Site

Omaha, Nebraska 68114-4113 - United States

Status: RECRUITING

Clinical Research Site

Cincinnati, Ohio 45229-3026 - United States

Status: RECRUITING

Clinical Research Site

Fort Worth, Texas 76104-2733 - United States

Status: RECRUITING

Clinical Research Site

Houston, Texas 77030-4000 - United States

Status: RECRUITING

Clinical Research Site

Randwick, New South Wales 2031 - Australia

Status: RECRUITING

Clinical Research Site

South Brisbane, Queensland 4101 - Australia

Status: RECRUITING

Clinical Research Site

Parkville, Victoria 3052 - Australia

Status: RECRUITING

Clinical Research Site

Nedlands, Western Australia 6009 - Australia

Status: RECRUITING

Clinical Research Site

Bruxelles, Brussels 1020 - Belgium

Status: RECRUITING

Clinical Research Site

Sint-Lambrechts-Woluwe, Brussels 1200 - Belgium

Status: RECRUITING

And 37 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Cytomegalovirus Infections:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships